Founded
31 Dec 2007
Address
Enobia Pharma Corp
2901 Rachel Street
Suite 23
Montreal QC H1W 4A4
Canada
Enobia Pharma Corp
2901 Rachel Street Suite 23
Montreal QC H1W 4A4
Canada
Enobia Pharma Corp
C/o Enobia Pharma Corp 2901 Rachel Street
Suite 23
Montreal QC H1W 4A4
Canada
Enobia Pharma Corp
C/o Enobia Pharma Inc
2901 Rachel Street Suite 23
Montreal QC H1W 4A4
Canada
Enobia Pharma Corp
C/o Enobia Pharma Corp., 2901 Rachel St.
Suite 23
Montreal QC H1W 4A4
Canada
Website
VCID: 380701
Profile
Corporate information
Official name
Enobia Pharma Corporation
Registration country
Official name
Enobia Pharma Corporation
Registration country
Investment activity status
Active investor
Funding
Funding rounds
Acquisition USD 1,100,000,000
USD 1,100,000,000 (28 Dec 2011) at USD 1,100,000,000 valuation.
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Alexion Pharmaceuticals Inc | Complement inhibition for cardiovascular and inflammatory diseases. | United States |
(1 Aug 2007)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Alexion Pharmaceuticals Inc Complement inhibition for cardiovascular and inflammatory diseases. |
Acquisition | |
|
Desjardins Venture Capital |
Series C | |
|
|
OrbiMed Advisors LLC American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
+1 (212) 739-6400 |
Series B |
|
|
Solidarity Fund QFL |
N/A | |
|
|
T2C2 Capital |
+1 (514) 842-9849 |
Series C |